Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01625546 · ClinicalTrials.gov registry record · NA
Whole Body Hyperthermia and Major Depression (MDD)
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01625546 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 34 participants.
The verdict
NCT01625546, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Major depressive disorder (MDD) is predicted to be the second leading cause of disability worldwide by the year 2020. The economic burden of depression in the United States is significant: $83.1 billion in 2000 and increasing. Much of this burden comes from the high rate of sub-optimal treatment outcomes associated with the disorder. Indeed, only 50% of MDD patients recover in less than 12 weeks with adequate treatment, and up to 20% of patients will fail to adequately respond to all currently available interventions. Moreover, current treatments come at the cost of significant central nervous system (CNS) side effects, further highlighting the need for more effective treatments with fewer side effects. This study will compare temperature ranges from the investigators preliminary studies involving thermoafferent pathways resulting in antidepressant actions with lower temperature ranges not expected to activate these pathways as a control condition, with the goal to evaluate whether previous observations were related to the temperature range in question or can be achieved with other levels.
Interventions
- DEVICE Whole Body Hyperthermia system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01625546
The ClinicalTrials.gov registry entry for NCT01625546 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole Body Hyperthermia system is the first listed.
NCT01625546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01625546 about?
NCT01625546 is a clinical study titled "Whole Body Hyperthermia and Major Depression (MDD)". Major depressive disorder (MDD) is predicted to be the second leading cause of disability worldwide by the year 2020. The economic burden of depression in the United States is significant: $83.1 billion in 2000 and increasing. Much of this burden comes from the high rate of sub-optimal treatment out...
What is the current status of trial NCT01625546?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2012-07. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01625546?
The interventions under investigation include: Whole Body Hyperthermia system (DEVICE).
Who is sponsoring clinical trial NCT01625546?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.